StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ALUVI.PA$2.50+3.73%
Fair $2.50+0.0%

ALUVI.PA

UV Germi SA

Industrials / Pollution & Treatment ControlsParis

$2.50

+0.09 (+3.73%)

Fairly Valued+0.0%Fair Value $2.50Fund rank 32/100 · Data gapFallback financials|
SA 45/C
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF n/d · quality 66.0/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 50/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

45/100

C

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 1.0%, below the 5% threshold
Thesis & Journal · ALUVI.PALocal privado en este navegador · UV Germi SA
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$6M

P/E

62.5x

↑

EV/EBITDA

4.4x

↓

ROE

1.0%

↓

Gross Margin

45.7%

↑

Debt/Equity

0.02

↓
52-Week Range$3
$2$4

TradingView lightweight chart

ALUVI.PA price, volumen y niveles de valoración

Último $2.500Periodo -55.2%
Fair value: $2.500

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-1.7%

FCF CAGR

—

FCF margin

—

FCF / Net income

—

Latest source

Provider fallback

Margin decomposition

Último año: revenue $6.8M · net income $101308.0 · FCF —

2022-FY → 2025-FY

Gross margin

45.7%+2.7% pts

Operating margin

1.3%-0.6% pts

Net margin

1.5%+0.6% pts

FCF margin

—— pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$6.8M$6.8M$8.5M$8.0M$7.2M
Net Income$101308.00$101308.00$709927.00$290088.00$65996.00
EBITDA$434829.00$434829.00$909987.00$617929.00$261654.00
EPS0.040.040.220.090.02
Gross Margin45.7%45.7%47.1%45.1%42.9%
Operating Margin1.3%1.3%6.7%7.0%1.9%
Net Margin1.5%1.5%8.3%3.6%0.9%
Balance Sheet
Debt/Equity0.020.020.010.020.09
Current Ratio7.807.80———
Returns
ROE1.0%1.0%7.2%3.2%0.7%
Valuation
P/E62.5062.5011.9641.00160.03
EV/EBITDA4.424.424.7514.1326.67
P/B0.610.610.861.311.20
Growth & Yield
Revenue Growth-20.1%-20.1%5.9%12.2%—
EPS Growth-81.1%-81.1%144.8%329.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

74.0%

muy exigente

EPS terminal req.

$0.22

Spread vs growth

-155.2%

5Y implied EPS CAGR

44.8%

muy exigente

EPS terminal req.

$0.27

Spread vs growth

-126.0%

10Y implied EPS CAGR

26.2%

muy exigente

EPS terminal req.

$0.43

Spread vs growth

-107.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +5.5%

Total return

+5.5%

Start / end P/E

10.6x → 59.4x

EPS bridge

0.22 → 0.04

Residual

-372.8%

EPS growth-81.1%
Multiple rerating+459.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term-372.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.